Italy In Vitro Diagnostics Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Italy's IVD market represents one of Europe's largest national diagnostic testing sectors, accounting for a significant share of the country's $14.76 billion medical devices industry. The market encompasses clinical chemistry, immunochemistry, molecular diagnostics, hematology, and point-of-care testing solutions used across hospitals, diagnostic laboratories, and clinical research settings.

• •Market valued at approximately $3.05 billion in 2025 with a 3.0% annual growth rate through 2030
• •Public healthcare spending and the National Health Service (SSN) procurement framework govern the majority of IVD consumption
• •Italy is a notable hub for IVD contract manufacturing, with a sub-segment projected to reach $962.6 million by 2030

The market's moderate growth reflects a normalization following the COVID-19 pandemic's exceptional surge in molecular and antigen testing demand. However, structural healthcare needs, including an aging population and rising prevalence of chronic diseases, continue to underpin stable demand for routine diagnostic testing.

• •Italy's National Recovery and Resilience Plan allocates significant funding toward digital modernization of clinical laboratories and diagnostic infrastructure
• •Aging demographics and increasing burden of chronic conditions such as diabetes, cardiovascular disease, and cancer drive demand for IVD tests
• •Point-of-care testing adoption and personalized medicine trends are expanding the addressable market beyond traditional hospital laboratory channels

The Italian IVD market spans multiple product and technology categories, with clinical chemistry and immunochemistry representing the largest segments by volume. Molecular diagnostics, while smaller in absolute terms, is among the faster-growing categories due to infectious disease testing needs and expanding applications in genetic and oncology diagnostics.

• •Contract manufacturing for IVD represents a distinct and high-growth sub-market, forecast at a 9.2% CAGR through 2030, positioning Italy as a European production center
• •Northern Italy, particularly Lombardy and Emilia-Romagna, concentrates the highest density of hospitals, research institutions, and advanced diagnostic facilities
• •Southern regions show growing demand as healthcare infrastructure investments under national development programs expand laboratory capacity

What are the recent trends and outlook?

Looking toward 2030, the market is expected to shift from pandemic-era volatility toward a steadier growth trajectory anchored by chronic disease management and preventive screening programs. Digital integration, automation, and laboratory information system connectivity are anticipated to reshape how IVD products are deployed and managed in Italian clinical settings.

• •Increased adoption of high-throughput automation and artificial intelligence-driven result interpretation in hospital laboratories
• •Growing emphasis on decentralized testing models using point-of-care and near-patient devices to reduce hospital congestion
• •Regulatory alignment with EU In Vitro Diagnostic Regulation (IVDR) is expected to reshape product registration and market access requirements through the forecast period